BIOBASED NANOEMULSION FOR BLOCKING COVID-19 FROM ACCELERATING ALZHEIMER'S DISEASE
An effective therapeutic strategy to delay dementia could be based upon nanotargeting drug(s), using lipid nanocarriers (i.e., biobased nanoemulsion technology), toward a major serum amyloid A (SAA) receptor responsible for certain proinflammatory, SAA-mediated, cell signaling events. For example, o...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Scientia Publishing House
2021-08-01
|
| Series: | Juvenis Scientia |
| Subjects: | |
| Online Access: | https://jscientia.org/index.php/js/user/setLocale/en_US?source=/index.php/js/article/view/54?utm_source=doaj |